Adenovirus Based Coronavirus Vaccine Being Tested
Greffex, Inc., a privately-held, multinational genetic engineering company headquartered in Houston, Texas has announced that it has completed development of a vaccine for the COVID-19 coronavirus. The vaccine will now proceed to testing in laboratory animals under supervision by the U.S Food and Drug Administration (FDA) and regulatory agencies in China.1 Greffex Got $18.9M from […]